NCT07364331

Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

Omega- 3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder With (OMNeADHD) A Double Blind Randomized Controlled Trial of High Dose Omega- 3 Fatty Acids in Children and Adolescents With ADHD With Omega- 3 Deficiency.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: China Medical University Hospital · Academic / Other
• Sex: All
• Age: 6 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.

Detailed description

This is a 12 week randomized controlled study on the effects of omega-3 fatty acids (EPA or DHA) in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.

Conditions

• ADHD
• Children
• Adolescents

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Omega-3	EPA or DHA
DIETARY_SUPPLEMENT	Placebo	olive oil

Timeline

• Start date: 2021-09-04
• Primary completion: 2026-07-31
• Completion: 2026-07-31
• First posted: 2026-01-23
• Last updated: 2026-01-26

Locations

1 site across 1 country: Taiwan